Patents by Inventor André Bernat

André Bernat has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Compositions for treating arterial thrombosis and a factor Xa inhibitor
    Patent number: 6541488
    Abstract: The invention relates to the use of direct or indirect selective inhibitors of factor Xa acting via antithrombin III, alone or in combination with one or more compounds with anti-platelet aggregation activity, for the preparation of medicines intended to prevent and to treat thromboembolic arterial diseases. The subject of the invention is also pharmaceutical compositions containing one or more direct or indirect selective inhibitors of factor Xa which act via antithrombin III in combination with one or more compounds with anti-platelet aggregation activity, and optionally one or more pharmaceutically acceptable vehicles.
    Type: Grant
    Filed: February 11, 2000
    Date of Patent: April 1, 2003
    Assignees: Sanofi-Synthelabo, Akzo Nobel
    Inventors: André Bernat, Jean Marc Herbert, Maurice Petitou, Ronald Van Amsterdam
  • Use of agonists of adrenergic &bgr;-3 receptors for preparing wound-healing medicines
    Patent number: 6235793
    Abstract: The invention relates to the use of &bgr;3-adrenergic receptor agonists for the preparation of healing drugs and to the pharmaceutical compositions for said use.
    Type: Grant
    Filed: July 15, 1999
    Date of Patent: May 22, 2001
    Assignee: Sanofi-Synthelabo
    Inventors: André Bernat, Jean-Marc Herbert, Michèle Arnone